Skip to Main Content

Jennifer Doudna

Professor, departments of chemistry and molecular and cell biology, University of California, Berkeley; founder, Innovative Genomics Institute

The Nobel-winning co-discoverer of the CRISPR genome-editing system, Doudna had a busy 2021. Her startup Mammoth Biosciences, which raised $195 million in September and achieved a “unicorn” valuation above $1 billion, developed a CRISPR-based diagnostic test for Covid-19 that received an emergency use authorization from the FDA in early 2022. Meanwhile, the Innovative Genomics Institute, which she founded at Berkeley, joined a study testing whether CRISPR can be used to correct the mutated gene that causes sickle cell disease.

From STAT:



  • 58


  • Berkeley, CA


The definitive list of authoritative leaders and influencers in health and life science

View the List